Voltage-gated ion channels play a critical role in coupling excitation at the neuromuscular junction to activation of contractile elements within a muscle fiber. Abnormal channel function can lead to either muscle paralysis or delayed relaxation. Recent advances in the molecular characterization of these ion channels have provided the tools needed to investigate the relationship between channel mutations and disorders of muscle excitability. This article reviews our current understanding of muscle sodium, calcium, and chloride channels and their role in the pathogenesis of myotonia and periodic paralysis. 1997 Academic Press
In skeletal muscle, contraction requires the participation of ion channels in the spread of an excitatory signal from the endplate region along the surface membrane and in coupling this signal in the T-tubules to the release of Ca 2ϩ from the sarcoplasmic reticulum. Failure of the sarcolemma to generate an action potential will cause muscle paralysis in spite of normal motor nerve, neuromuscular junction, and contractile protein function. Conversely, hyperexcitability of the sarcolemma, with multiple action potentials in response to a single input at the neuromuscular junction, can produce abnormally sustained muscle contraction that also adversely affects function. Mutations in skeletal muscle sodium, chloride, and calcium channels have recently been implicated in producing effects such as these in humans.
For many years, clinicians have recognized muscle diseases that are associated with either increased or decreased membrane excitability. Of the two, hyperexcitability or myotonia is more frequently encountered; multiple action potentials in response to a brief stimulus produce the repetitive discharges that are the electrophysiological hallmark of myotonia and lead to the sustained contraction of voluntary muscle noted by the affected individual. Myotonia is seen as the primary symptom in several disorders; the most common of these are the recessive and dominant forms of myotonia congenita (for a review of the clinical features of the myotonic disorders, see Becker, 1977; Barchi, 1992) . Myotonia is also a prominent feature of the recessively inherited Schwartz-Jampel syndrome (Schwartz & Jampel, 1962) and is a characteristic finding in myotonic dystrophy.
Decreased sarcolemmal excitability causes the weakness seen in the periodic paralyses. This group of muscle disorders (reviewed in Schipperheyn et al., 1992) is characterized by episodes of skeletal muscle weakness or paralysis that often occur on the background of normal interictal strength. Most forms of periodic paralysis are hereditary, and in a given pedigree the serum potassium characteristically rises or falls during a paralytic episode, leading to the standard clinical nomenclature of hyperkalemic periodic paralysis (HyPP) and hypokalemic periodic paralysis (HoPP). In a third disorder, paramyotonia congenita (PC), episodes of paralysis are rare and other features of membrane hyperexcitability are often predominant. Although the various periodic paralyses share many clinical features, recent molecular analyses have uncovered fundamental differences in their pathophysiology.
